Genexine, Inc. (KOSDAQ: 095700)
South Korea
· Delayed Price · Currency is KRW 5,080.00
-50.00 (-0.97%)
Jan 21, 2025, 9:00 AM KST
Genexine Revenue
Genexine had revenue of 2.07B KRW in the quarter ending March 31, 2024, with 199.63% growth. This brings the company's revenue in the last twelve months to 5.81B, down -3.50% year-over-year. In the year 2023, Genexine had annual revenue of 4.43B, down -72.57%.
Revenue (ttm)
5.81B
Revenue Growth
-3.50%
P/S Ratio
36.11
Revenue / Employee
67.53M
Employees
86
Market Cap
231.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4.43B | -11.71B | -72.57% |
| Dec 31, 2022 | 16.14B | -20.69B | -56.18% |
| Dec 31, 2021 | 36.83B | 18.28B | 98.61% |
| Dec 31, 2020 | 18.54B | 7.24B | 64.06% |
| Dec 31, 2019 | 11.30B | 5.05B | 80.80% |
| Dec 31, 2012 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
| Dec 31, 2009 | Pro | Pro | Pro |
| Dec 31, 2008 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 292.86T |
| SK hynix | 57.73T |
| LG Energy Solution | 27.17T |
| Samsung Biologics Co.,Ltd. | 4,364.39B |
| Hyundai Motor Company | 170.28T |
| Kia Corporation | 104.63T |
| Celltrion | 2,876.25B |
| KB Financial Group | 14.11T |